On Apr 24, 2026, NMR reported earnings of 25.35 USD per share (EPS) for Q4 26, missing the estimate of 35.06 USD, resulting in a -27.70% surprise. Revenue reached 577.18 billion, compared to an expected 1.18 trillion, with a -50.91% difference. The market reacted with a +0.75% price change (close before vs. close after earnings).
Looking ahead to Q1 27, 2 analysts forecast an EPS of 29.81 USD, with revenue projected to reach 542.72 billion USD, implying an increase of 17.59% EPS, and decrease of -5.97% in Revenue from the last quarter.